日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy

CD33表位编辑技术使UM171扩增的脐带血移植可用于急性髓系白血病免疫治疗。

Lehnertz, Bernhard; Langouët, Maéva; Corneau, Sophie; MacRae, Tara; Joe, Maju; Schmidt, Edward N; Spinella, Jean-Francois; Mayotte, Nadine; Moore, Susan; Tellechea, Maria Florencia; Boivin, Isabel; Papineau, Loïc; Rojas-Sutterlin, Shanti; Tual, Margaux; Cortes, Camille Jimenez; Chagraoui, Jalila; Tomellini, Elisa; Desse, Virginie; Gagnon, Etienne; Macauley, Matthew S; Sauvageau, Guy

A commentary on: "CD33 drives cutaneous melanoma: mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression"

对以下文章的评论:“CD33驱动皮肤黑色素瘤:孟德尔随机化证实了因果关系,多组学和体外实验揭示了M2巨噬细胞极化介导的进展”

Sun, Xiaoqi; Xu, Lihui; Ni, Suqin

Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia

在急性髓系白血病中,CD33靶向双特异性T细胞共刺激增强CD117靶向双特异性T细胞的参与。

Hofstetter, Mara; Volta, Laura; Koch, Christian; Rey, Melanie Granados; Maurer, Monique; Gönüllü, Nagihan; Pellegrino, Christian; Gobbi, Celeste; Schneiter, Florin; Manfredi, Francesco; Magnani, Chiara F; Elsayed, Abdullah; Schroeder, Timm; Neri, Dario; Manz, Markus G

Humanized anti-CD33 CAR-T cells and antibody-drug conjugates for targeted therapy in acute myeloid leukemia

人源化抗CD33 CAR-T细胞和抗体药物偶联物用于急性髓系白血病的靶向治疗

Chen, Lijun; Duan, Honghong; Huang, Chunling; Xu, Yajing; Wang, Zitong; Huang, Huibin

CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML

分泌抗CD33/抗CD3双靶向抗体的CD70 CAR T细胞可克服急性髓系白血病中的抗原异质性。

Silva, Harrison J; Martin, Grace; Birocchi, Filippo; Wehrli, Marc; Kann, Michael C; Supper, Valentina; Parker, Aiyana; Graham, Charlotte; Bratt, Alexandra; Bouffard, Amanda; Donner, Hannah; Escobar, Giulia; Takei, Hana; Armstrong, Alexander; Goncalves, Sadie; Berger, Trisha R; Choi, Bryan D; Maus, Marcela V; Leick, Mark B

Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy.

多重碱基编辑技术可防止 CD33 靶向药物对免疫和基因治疗产生影响。

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

用于治疗骨髓驻留髓系恶性肿瘤的同种异体CD33靶向CAR-NKT细胞

Yan-Ruide Li # ,Ying Fang # ,Siyue Niu # ,Yichen Zhu # ,Yuning Chen ,Zibai Lyu ,Enbo Zhu ,Yanxin Tian ,Jie Huang ,Valerie Rezek ,Scott Kitchen ,Tzung Hsiai ,Jin J Zhou ,Pin Wang ,Wanxing Chai-Ho ,Sunmin Park ,Christopher S Seet ,Caspian Oliai ,Lili Yang

Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial

CD33靶向CAR-NK细胞疗法治疗复发/难治性急性髓系白血病的安全性和有效性:临床前评估和I期试验

Huang, Ruihao; Wang, Xiaoqi; Yan, Hongju; Tan, Xu; Ma, Yingying; Wang, Maihong; Han, Xiao; Liu, Jia; Gao, Li; Gao, Lei; Jing, Guangjun; Zhang, Cheng; Wen, Qin; Zhang, Xi

CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells

CD33-CD123 IF-THEN 门控可降低 AML 靶向 CAR-T 细胞的毒性,同时增强其特异性和记忆表型。

Jambon, Samy; Sun, Jianping; Barman, Shawn; Muthugounder, Sakunthala; Bito, Xue Rachel; Shadfar, Armita; Kovach, Alexandra E; Wood, Brent L; Thoppey Manoharan, Varsha; Morrissy, A Sorana; Bhojwani, Deepa; Wayne, Alan S; Pulsipher, Michael A; Kim, Yong-Mi; Asgharzadeh, Shahab; Parekh, Chintan; Moghimi, Babak

CD33(KO)-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia

CD33(KO)-CD33-间皮素环状CAR设计避免了同胞相残杀,并提高了iNK细胞对抗急性髓系白血病的疗效。

Wang, Yao; Zheng, Xiujuan; Wang, Zhiqian; Xiao, Ziyun; Lin, Yunqing; Zhang, Fan; Liu, Yanhong; Liu, Pengcheng; Weng, Qitong; Zhang, Leqiang; Xia, Chengxiang; Huang, Dehao; Liu, Lijuan; Zhu, Yanping; Zhang, Qi; Qi, Hanmeng; Chen, Yi; Shen, Yiyuan; Zhang, Chenyuan; Xu, Jiacheng; Zhao, Yaoqin; Wu, Jiaxin; Wang, Tongjie; Zhang, Mengyun; Li, Minming; Qian, Wenbin; Liang, Aibin; Du, Xin; Yang, Wenyu; Hu, Tianyuan; Chen, Qi; Zhu, Xiaofan; Hu, Fangxiao; Wang, Jinyong